Regentis Biomaterials Ltd. (RGNT) News
Follow Regentis Biomaterials Ltd. (RGNT) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Regentis Biomaterials and the Shift from Symptom Management to Structural Repair in Knee Cartilage Care
Austin, Texas, United States, September 29th, 2026, FinanceWireFor much of the last three decades, treatment of degenerative knee disease has centered heavily on managing symptoms with anti-inflammatories, activity modif
NEWS | Sep 29, 2026, 04:21 PM UTC
L
Regentis Biomaterials Receives European Regulatory Approval For New GelrinC Manufacturing Process
The approval comes as Regentis prepares for the commercial launch of GelrinC® in Europe, enabling the Company to manufacture commercial product using a process that increases production yield by approximately 400%, deliv
RATES | Jul 15, 2026, 01:02 PM UTC
L
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Can Fite Biopharma (AMEX: CANF ) shares rose 43.8% to $4.27 during Wednesday's regular session. The company's market cap stands at $6.3 million. Regencell Bioscience (NASDAQ: RGC ) stock moved upwards by 35.79% t
EQUITY | Jul 01, 2026, 05:05 PM UTC